Month: August 2018 - Page 2 - DrugPatentWatch

How to Use Tentative Drug Approvals to Anticipate Generic Entry

One powerful tool that savvy industry professionals use to gain a competitive edge is the analysis of tentative drug approvals. […]

How to Use Tentative Drug Approvals to Anticipate Generic Entry Read Post »

Guest Content, Insights

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study

This paper was originally published by Rishi J Desai, Ameet Sarpatwari, Sara Dejene, Nazleen F Khan, Joyce Lii, James R Rogers, Sarah K Dutcher, Saeid Raofi, Justin Bohn,

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study Read Post »

Insights

Ten years of biosimilars in Europe: development and evolution of the regulatory pathways

This paper was originally published by Martin Schiestl, Markus Zabransky, and Fritz Sörgel in Drug Des Devel Ther. 2017; 11: 1509–1515 under

Ten years of biosimilars in Europe: development and evolution of the regulatory pathways Read Post »